Sveriges mest populära poddar
The Long Run with Luke Timmerman
Vetenskap

Ep200: Richard Pops Reflects on a 35-Year Career in Biotech

1 tim 14 min•5 maj 2026
Alkermes CEO Richard Pops reflects on his 35-year career leading the company and its new opportunity in orexin biology for sleep disorders and more neurological conditions.

Fler avsnitt av The Long Run with Luke Timmerman

Visa alla avsnitt av The Long Run with Luke Timmerman
Ep203: Sri Kosuri on Small Molecule Correctors of Disease
•1 tim 12 min
Ep202: Becky Pferdehirt on Reimagining Science for the AI Era
•1 tim 8 min
Ep201: Jeremy Levin on Biotech in the Balance
•1 tim 9 min
Ep199: Martin Burke on Making Small Molecule Medicines for the AI Era
•1 tim 10 min
Ep198: Abbas Kazimi on Computation and Culture for Drug Discovery
•1 tim 17 min
Ep197: Viswa Colluru on Discovering Drugs Inspired by Mother Nature
•1 tim 17 min
Ep196: Otello Stampacchia on Europe's Biotech Crisis
•1 tim 3 min
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
•1 tim 6 min
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery
•1 tim 9 min
Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
•1 tim 5 min

The Long Run with Luke Timmerman med Timmerman Report finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.